Furthermore, a more recent detailed analysis of this model with anti-angiogenic and anti-PD-L1 treatment showed the transition from tumor endothelial cells into HEVs based on LT-β receptor signaling by NK and CD8 T cells, thus promoting the expansion of anti-tumor effector T cells (75). This evidence concerns the gene CD8A and neoplasm.